Blackstone, Clears

Blackstone Clears Major Hurdle in $11.5 Billion Energy Acquisition

24.02.2026 - 06:21:15 | boerse-global.de

FERC approves Blackstone's $11.5B TXNM Energy acquisition, dismissing competition concerns. Deal advances despite stock decline and pending state approvals.

Blackstone Clears Major Hurdle in $11.5 Billion Energy Acquisition - Foto: über boerse-global.de

The private equity giant Blackstone has secured a crucial federal approval for its planned $11.5 billion purchase of utility company TXNM Energy. The U.S. Federal Energy Regulatory Commission (FERC) granted its clearance, determining the deal serves the public interest and dismissing concerns raised by critics. This decision significantly advances one of the investment manager's most substantial ongoing infrastructure transactions.

Regulatory Scrutiny Overcome

FERC's authorization follows an intensive review period. Opponents of the deal had expressed worries that Blackstone's extensive investments in power-intensive data centers could create conflicts of interest or increase electricity costs for consumers. The regulator concluded, however, that it found no evidence the merger would harm market competition or lead to higher prices for customers.

While this green light substantially de-risks the project for Blackstone, the market reaction was muted. Many investors had already priced in a favorable outcome. To secure the deal in Texas, Blackstone had previously made concessions, including commitments for customer bill credits and a guarantee that acquisition costs would not be passed through to ratepayers.

Stock Performance and Strategic Diversification

Operationally, Blackstone's shares face headwinds. The stock recently touched a new 52-week low, closing at 96.51 euros, and has declined nearly 29% since the start of the year.

This movement occurs as the firm aggressively diversifies beyond its core holdings. Just yesterday, its Blackstone Life Sciences division entered a collaboration with Johnson & Johnson to fund the clinical development of a new drug for acute myeloid leukemia. Furthermore, the company has increased its stake in AI specialist Anthropic to approximately $1 billion. These moves highlight a strategic push to direct more capital into high-growth technology and healthcare markets.

Should investors sell immediately? Or is it worth buying Blackstone?

Pending Approvals and Future Outlook

Despite this key federal regulatory success, the TXNM Energy acquisition is not yet finalized. Approvals from state regulators in New Mexico and from the Nuclear Regulatory Commission are still pending.

Investors seeking a detailed look at the firm's financial performance and the progress of its active acquisitions will get their chance on April 16, 2026. Blackstone's management is scheduled to release its first-quarter results on that date.

Ad

Blackstone Stock: New Analysis - 24 February

Fresh Blackstone information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Blackstone analysis...

So schätzen die Börsenprofis Blackstone Aktien ein!

<b>So schätzen die Börsenprofis Blackstone Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
US09260D1072 | BLACKSTONE | boerse | 68606481 |